A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO)
BACKGROUND: Elderly patients are commonly under-represented in cancer clinical trials. The 321GO was undertaken in preparation for a definitive phase three trial assessing different chemotherapy regimens in a frail and/or elderly population with advanced gastroesophageal (GO) cancer. METHODS: Patien...
Main Authors: | Hall, P, Lord, S, Collinson, M, Marshall, H, Jones, M, Lowe, C, Howard, H, Swinson, D, Velikova, G, Anthoney, A, Roy, R, Dent, J, Cheeseman, S, Last, K, Seymour, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Cancer Research UK
2017
|
Similar Items
-
COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes
by: Roland Kunz, et al.
Published: (2020-03-01) -
How frail is frail in oncology studies? A scoping review
by: James A. Fletcher, et al.
Published: (2023-06-01) -
Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial
by: Mark A. Baxter, et al.
Published: (2023-05-01) -
Prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO): study protocol for a randomized, controlled, outcome assessor-blinded trial
by: Stefan J. Schaller, et al.
Published: (2022-06-01) -
Morphology of paraspinal muscles in frail and non-frail older adults evaluated through FRAIL scale
by: Rufeng Huang, et al.
Published: (2023-01-01)